Michael Perry

Insider Reports History

Entity
Individual
Location
C/O Biotransplant Inc, 196 Boston Ave Suite 2800, Medford, MA
Signature
/s/Michael Perry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Perry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARROWHEAD PHARMACEUTICALS, INC. Director Common Stock 131K $3.02M $22.99 Dec 18, 2024 Direct
AVITA Medical, Inc. Director Common Stock 230K $2.86M $12.45 Nov 21, 2022 Direct
AVITA Medical, Inc. Director Stock Options (Right to Buy) 0 Nov 21, 2022 Direct

Insider Reports Filed by Michael Perry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARWR ARROWHEAD PHARMACEUTICALS, INC. Dec 18, 2024 1 $385K 4 Dec 20, 2024 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Dec 15, 2023 1 $381K 4 Dec 19, 2023 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 10, 2023 2 $0 4 Jan 11, 2023 Director
RCEL AVITA Medical, Inc. Nov 21, 2022 3 -$179K 4 Nov 22, 2022 Director
RCEL AVITA Medical, Inc. Sep 1, 2022 2 $0 4 Sep 6, 2022 Chief Executive Officer, Director
RCEL AVITA Medical, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Chief Executive Officer, Director
RCEL AVITA Medical, Inc. Feb 23, 2022 4 -$94.5K 4 Feb 25, 2022 Chief Executive Officer, Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 7, 2022 1 $0 4 Jan 7, 2022 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 3, 2022 3 -$291K 4 Jan 4, 2022 Director
RCEL AVITA Medical, Inc. Dec 22, 2021 6 $0 4 Dec 27, 2021 Chief Executive Officer, Director
RCEL AVITA Medical, Inc. Sep 1, 2021 2 -$232K 4 Sep 7, 2021 Chief Executive Officer, Director
RCEL AVITA Medical, Inc. Jun 2, 2021 1 -$399K 4 Jun 4, 2021 Chief Executive Officer, Director